From the Coagulation and Blood Research (Blood) (T.C.C., X.W., J.D.K., J.G.-M., C.L.S., B.L., A.P.C., J.A.B.), United States Army Institute of Surgical Research, San Antonio, Texas; Capricor Therapeutics Institute (J.J.M., K.A.P., L.R.-B., N.A.A., L.S.M.), Beverly Hills, California; Department of Biological Chemistry (S.J.G.), Johns Hopkins, Baltimore, Maryland; and Department of Biomedical Engineering (C.R.R.), The University of Texas at San Antonio, San Antonio, Texas.
Submitted: December 15, 2020, Revised: February 3, 2021, Accepted: February 12, 2021, Published online: April 8, 2021.
This study is respectfully being submitted for consideration into the Military Health System Research Symposium; 2021 Military Supplement.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text, and links to the digital files are provided in the HTML text of this article on the journal’s Web site (www.jtrauma.com).
Address for reprints: Tiffani C. Chance, PhD, Coagulation and Blood Research (Blood), United States Army Institute of Surgical Research, 3650 Chambers Pass, Bldg 3610, JBSA-Fort Sam Houston, TX 78234-4504; email: [email protected].
